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ABSTRACT
Objective: Both Vitamin C and Vitamin E supplementation were associated with reduction in blood pressure (BP) in observational studies, although, 
results of clinical trials are inconsistent. The objective of our study is to conduct a clinical trial to observe the effects of oral supplementation of 
Vitamin C and Vitamin E on BP.
Methods: About 60 non-teaching staffs of our college with systolic BP more than 130 mmHg and diastolic BP more than 90 mmHg were taken as 
subjects and divided into two groups. Initial BP and BP after oral Vitamin C, 500 mg/day for a period of 12 weeks to Group 1 and initial BP and BP after 
oral Vitamin E, 200 IU/day, for a period of 12 weeks to Group 2 were recorded.
Results: Statistical analysis was done by paired t-test, analysis of variance (ANOVA), and least significant difference (LSD) tests. *p<0.05 was 
considered statistically significant. Systolic 2 and diastolic 2 – after 3 months of supplementation showed 0.161 and 0.161 which is not significant. 
ANOVA and LSD tests show no significant results.
Conclusion: Long-term trials on the effects of Vitamin C and Vitamin E supplementation on BP and clinical events are needed.
Keywords: Systolic blood pressure, Diastolic blood pressure, Vitamin C, Vitamin E.
INTRODUCTION
Vitamin C is an important antioxidant vitamin, presents in citrus 
fruits, vegetables, fortified beverages, and cereals [1]. Vitamin C 
reduces oxidative stress [2] and improves endothelial function by 
increasing nitric oxide production [3]. Antihypertensive effects of 
Vitamin C were documented as early as 1946 [4], in both animal [5,6] 
and human studies [7,8]. Population-based observational studies 
have also proved the effect of Vitamin C in reducing blood pressure 
(BP) [9,10]. Both Vitamins C and E are potent scavengers of free 
radicals that activate nitric oxide synthase in endothelial cells [11] 
and thereby reduce the BP [11-13]. Vitamin E inhibits the expression 
of adhesion molecules [14], and, consequently, vascular structural 
changes associated with hypertension. Vitamins C and E prevent 
oxidation of proteins and lipids by scavenging free radicals and 
thereby protect against oxidative stress [15]. Vitamin E [16,17] may 
modulate the interactions between cytochrome b558, the membrane-
bound part of nicotinamide adenine dinucleotide (P) H oxidase that is 
essential for both the activity and stability of the enzyme. The previous 
studies have proved that in mild-to-moderate hypertensive patients, 
supplementation with ascorbic acid (500 mg/day) significantly 
improved systolic and diastolic BP (DBP) [18] and increased plasma 
high-density lipoprotein (HDL) cholesterol in female. The aim of the 
study is to explore the effect of Vitamin C and Vitamin E on hypertension 
and to conclude which vitamin supplement will be a better choice for 
hypertension.
METHODS
Our study is a prospective study, carried out in the Department of 
Biochemistry at Sri Lakshmi Narayana Institute of Medical Sciences, 
Puducherry.
Sample size
About 60 non-teaching staffs were enrolled as subjects after getting 
written informed consent.
Inclusion and exclusion criteria
Those subjects with systolic BP (SBP) >130 mmHg and diastolic pressure 
>90 mmHg were enrolled. Those with uncontrolled hypertension 
(SBP >180 mmHg and/or DBP >100 mmHg) were excluded from the 
study. Ethical clearance from the institutional ethical committee was 
obtained. Demographic details such as age, sex, and history of underlying 
diseases were obtained. After measuring the initial BP using a manual 
sphygmomanometer, the patients were divided into two groups of 30 
in each group and supplemented with oral dosage of Vitamin C 500 mg 
(CELIN 500, GlaxoSmithKline, Ahmadabad) (0-0-1) for Group 1 and 
Vitamin E, 200 IU (Evion 200) (0-0-1) for Group 2 along with their regular 
antihypertensive drug. The BP was recorded after a period of 12 weeks.
RESULTS AND DISCUSSION
All data were expressed as mean±standard deviation and statistical 
analysis was carried out using paired t-test. To evaluate the significance 
between the two groups studied, analysis of variance (ANOVA) and 
least significant difference (LSD) tests were performed by fixing the 
statistical significance level at *p<0.05.
The bar diagrams (Figs. 1 and 2) represent the changes in the SBP and 
DBP before (1) and after (2) 3 months of Vitamin C supplementation. 
The results are expressed as mean ± standard error of the mean (SEM), 
*p<0.05 is considered statistically significant.
The results are expressed as mean±SEM; *p<0.05 is considered 
statistically significant.
The bar diagrams (Fig. 3 and 4) represent the changes in the SBP and 
DBP before (1) and after 3 months of (2) the vitamin supplementation.
Statistical analysis
Paired t-test is done with the mean of both SBP and DBP of the “affected 
subjects” before the supplementation and 12 weeks after the vitamin 
supplementations, taking *p<0.05 as statistically significant.
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From our study, we found that 2 subjects (7%) and 3 subjects (10%) 
receiving Vitamin C and E, respectively, showed reduction in SBP 
(2–4 mmHg) and DBP (2–4 mmHg). The major findings of our study are 
that Vitamin C and E had a mild positive effect on BP. In recent studies, it 
is proved that Vitamin C improves nitric oxide bioactivity [18,19] which 
is a potent vasodilator and can reduce the BP. This is seen to a lesser 
extent in our study due to the time factor and fewer subjects. Clinical 
studies show the BP reducing effect of Vitamin C, particularly in elderly 
patients [19,20]. In a Primary Prevention Project, where hypertensive 
patients were treated with Vitamin E, there were no clinically relevant 
effects on BP [21]. Another trial including supplementation with 
Vitamins C and E proved that the urinary microalbumin excretion and 
BP were decreased in the study group [22]. In another study, using 2 g 
of Vitamin C for 90 days showed a decrease of total cholesterol (TC), 
Fig. 2: The mean of diastolic blood pressures before Vitamin C 
supplementation was 95 mmHg while it was 91 mmHg after 
3 months
Fig. 3: The mean of systolic blood pressures before Vitamin E 
supplementation was 135.3 mmHg while it was 132 mmHg, after 
3 months
95% confidence 




Systolic: 1,  
Systolic: 2




1.7735 −0.797 29 0.432
Pair 1: Pair 1 is systolic blood pressure 1 and 2 (before and after 12 weeks 
of supplementation, respectively). Taking *p<0.05, as statistically significant, 
value of pair 1 is 0.161 which is not statistically significant. Pair 2: Pair 2 is 
diastolic blood pressure 1 and 2 (before and after 12 weeks of supplementation, 
respectively). Taking *p<0.05, as statistically significant, value of pair 1 is 0.161 
which is not statistically significant
95% confidence 










0.7296 1.720 29 0.096
Pair 1: Pair 1 is systolic blood pressure 1 and 2 (before and 12 weeks after the 
supplementation). Taking *p<0.05, the value of pair 1 is 0.096 which is not 
statistically significant. Pair 2: Pair 2 is diastolic blood pressure 1 and 2 (before 
and 12 weeks after the supplementation). Taking *p<0.05, as statistically 
significant, the value of pair 1 is 0.096 which is not statistically significant. 
Analysis of variance and post hoc tests (least significant difference ) were done 





Between groups 11.467 2 5.733 0.343 0.711
Within groups 1454.133 87 16.714
Total 1465.600 89
Diastolic
Between groups 112.267 2 56.133 1.988 0.143
Within groups 2456.133 87 28.231
Total 2568.400 89
Analysis of variance is taken for the systolic and diastolic blood pressure of the 
subjects of Vitamins C and E after 12 weeks of supplementation. Taking *p<0.05, 
since the values are more than 0.05, there is no statistical significance
Fig. 1: The mean of systolic blood pressures before 
Vitamin C supplementation was 134 mmHg while it was 
130 mmHg after 3 months
Paired differences t df Sig. 
(two tailed)
Paired differences t df Sig. 
(two tailed)
Table 2: Vitamin E: Paired samples test
Table 1: Vitamin C: Paired samples test
Sum of 
squares
Table 3: Analysis of variance
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Vitamin E −0.3333 1.0556 0.753
Vitamin D3 Vitamin C −0.5333 1.0556 0.615
Vitamin E −0.8667 1.0556 0.414
Vitamin E Vitamin C 0.3333 1.0556 0.753
Vitamin D3 0.8667 1.0556 0.414
Diastolic LSD Vitamin C Vitamin D3 2.7333* 1.3719 0.049
Vitamin E 1.2667 1.3719 0.358
Vitamin D3 Vitamin C −2.7333* 1.3719 0.049
Vitamin E −1.4667 1.3719 0.288
Vitamin E Vitamin C −1.2667 1.3719 0.358
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LSD: Least significant difference
which, in turn, may decrease the BP [23]. Certain studies have also 
shown that Vitamin E, 600 or 1200 mg/day for 2 months [24], play a role 
in decreasing oxidative stress in Type 2 diabetes. Studies have shown 
that Vitamin E significantly reduces plasma low-density lipoprotein 
(LDL) oxidation by 60% in diabetic patients [25]. In the study by Omar 
et al. combined Vitamins A, C, and E (ANTOX) twice daily for 3 months 
caused a significant decrease in fasting blood glucose, postprandial 
blood glucose, hemoglobin A1C, TC, triglycerides, and LDL and increase 
in HDL level [26]. In recent study on polyherbal preparation of Bellerica 
fructus or Terminalia bellerica, C. aeruginosa rhizome has proved to 
have antioxidant and antihypertensive effects [27].
CONCLUSION
From the above study, we conclude that supplementation of Vitamins C 
and E can decrease BP and can be taken by people who are in borderline 
risk for hypertension. From our study, it was found that compared to 
Vitamin C, Vitamin E had slightly more benefits in lowering the BP. 
Although our study is a short time study with fewer subjects, we found 
that vitamins do have a role in reducing the BP.
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Dependent variable (I) VAR00001 (J) VAR00001 Mean difference (I‑J) Std. error Sig.
Systolic LSD Vitamin C Vitamin D3 0.5333 1.0556 0.615
Table 4: Post hoc test (LSD method) 
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